Thomson Reuters profit beats, finance unit shows growth
(Reuters) – Thomson Reuters Corp on Wednesday reported higher-than-expected quarterly profit as the company’s biggest division that serves banks and financial institutions showed underlying revenue growth for the first time since 2011.
Thomson Reuters profit beats, finance unit shows growth
(Reuters) – Thomson Reuters Corp on Wednesday reported higher-than-expected quarterly profit as the company’s biggest division that serves banks and financial institutions showed underlying revenue growth for the first time since 2011.
BAT sees ‘plain packaging’ challenge in Britain being heard in December
LONDON (Reuters) – British American Tobacco expects its legal challenge to the implementation of “plain packaging” of tobacco in Britain to be heard in court in December, with possible final resolution by the end of 2016, a senior executive said.
Weak home purchase contracts hint at pause in sales activity
WASHINGTON (Reuters) – Contracts to buy previously owned U.S. houses unexpectedly fell in June after five straight months of increase, suggesting some cooling in home resales activity after recent hefty gains.
Judge dismisses ‘pyramid scheme’ lawsuit versus Herbalife, CEO
(Reuters) – A federal judge has dismissed a lawsuit accusing Herbalife Ltd and its chief executive officer of misrepresenting the weight-loss and nutritional products maker’s sales practices as legitimate when the company was “at its core” a pyramid sc…
U.S. pending home sales take a breather in June
WASHINGTON (Reuters) – Contracts to buy previously owned U.S. homes unexpectedly fell in June after five straight months of increase, suggesting some cooling in sales activity after recent hefty gains.
GM to invest $1 billion in India to boost exports
NEW DELHI (Reuters) – General Motors Co said on Wednesday it will invest $1 billion over the next few years to turn India into a global export hub, even as it cuts production capacity in the country due to sluggish demand.
GSK flags up pipeline as HIV drugs help it beat profit forecasts
LONDON (Reuters) – GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts.
GSK flags up pipeline as HIV drugs help it beat profit forecasts
LONDON (Reuters) – GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts.
Carlyle’s second-quarter earnings drop as energy funds suffer
(Reuters) – Private equity firm Carlyle Group LP said on Wednesday its second-quarter earnings dropped 38 percent year-on-year as the value of its energy and hedge funds decreased, even as it generated more cash by cashing out on several of its assets….
